1 Market Overview

1.1 Product Overview and Scope of Benign Prostatic Hyperplasia Treatment Equipments

1.2 Classification of Benign Prostatic Hyperplasia Treatment Equipments by Type

1.2.1 Overview: Global Benign Prostatic Hyperplasia Treatment Equipments Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Type in 2020

1.2.3 Surgical Treatment Equipments

1.2.4 Minimally Invasive Treatment Equipments

1.2.5 Laser Treatment Equipments

1.2.6 Other

1.3 Global Benign Prostatic Hyperplasia Treatment Equipments Market by Application

1.3.1 Overview: Global Benign Prostatic Hyperplasia Treatment Equipments Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals and Clinics

1.3.3 Ambulatory Surgical Centers(ASC)

1.3.4 Home

1.3.5 Others

1.4 Global Benign Prostatic Hyperplasia Treatment Equipments Market Size & Forecast

1.5 Global Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast by Region

1.5.1 Global Benign Prostatic Hyperplasia Treatment Equipments Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Benign Prostatic Hyperplasia Treatment Equipments Market Size by Region, (2016-2021)

1.5.3 North America Benign Prostatic Hyperplasia Treatment Equipments Market Size and Prospect (2016-2026)

1.5.4 Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size and Prospect (2016-2026)

1.5.6 South America Benign Prostatic Hyperplasia Treatment Equipments Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Benign Prostatic Hyperplasia Treatment Equipments Market Drivers

1.6.2 Benign Prostatic Hyperplasia Treatment Equipments Market Restraints

1.6.3 Benign Prostatic Hyperplasia Treatment Equipments Trends Analysis

2 Company Profiles

2.1 Advin Urology

2.1.1 Advin Urology Details

2.1.2 Advin Urology Major Business

2.1.3 Advin Urology Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.1.4 Advin Urology Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Advin Urology Recent Developments and Future Plans

2.2 Biolitec

2.2.1 Biolitec Details

2.2.2 Biolitec Major Business

2.2.3 Biolitec Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.2.4 Biolitec Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Biolitec Recent Developments and Future Plans

2.3 Boston Scientific Corporation

2.3.1 Boston Scientific Corporation Details

2.3.2 Boston Scientific Corporation Major Business

2.3.3 Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.3.4 Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Boston Scientific Corporation Recent Developments and Future Plans

2.4 CONMED

2.4.1 CONMED Details

2.4.2 CONMED Major Business

2.4.3 CONMED Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.4.4 CONMED Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 CONMED Recent Developments and Future Plans

2.5 Convergent Laser Technologies

2.5.1 Convergent Laser Technologies Details

2.5.2 Convergent Laser Technologies Major Business

2.5.3 Convergent Laser Technologies Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.5.4 Convergent Laser Technologies Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Convergent Laser Technologies Recent Developments and Future Plans

2.6 CoreTherm Medical, Inc.

2.6.1 CoreTherm Medical, Inc. Details

2.6.2 CoreTherm Medical, Inc. Major Business

2.6.3 CoreTherm Medical, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.6.4 CoreTherm Medical, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 CoreTherm Medical, Inc. Recent Developments and Future Plans

2.7 HistoSonics, Inc.

2.7.1 HistoSonics, Inc. Details

2.7.2 HistoSonics, Inc. Major Business

2.7.3 HistoSonics, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.7.4 HistoSonics, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 HistoSonics, Inc. Recent Developments and Future Plans

2.8 JenaSurgical GmbH

2.8.1 JenaSurgical GmbH Details

2.8.2 JenaSurgical GmbH Major Business

2.8.3 JenaSurgical GmbH Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.8.4 JenaSurgical GmbH Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 JenaSurgical GmbH Recent Developments and Future Plans

2.9 KARL STORZ

2.9.1 KARL STORZ Details

2.9.2 KARL STORZ Major Business

2.9.3 KARL STORZ Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.9.4 KARL STORZ Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 KARL STORZ Recent Developments and Future Plans

2.10 LISA Laser Products GmbH

2.10.1 LISA Laser Products GmbH Details

2.10.2 LISA Laser Products GmbH Major Business

2.10.3 LISA Laser Products GmbH Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.10.4 LISA Laser Products GmbH Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 LISA Laser Products GmbH Recent Developments and Future Plans

2.11 Lumenis Ltd.

2.11.1 Lumenis Ltd. Details

2.11.2 Lumenis Ltd. Major Business

2.11.3 Lumenis Ltd. Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.11.4 Lumenis Ltd. Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Lumenis Ltd. Recent Developments and Future Plans

2.12 Medifocus, Inc

2.12.1 Medifocus, Inc Details

2.12.2 Medifocus, Inc Major Business

2.12.3 Medifocus, Inc Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.12.4 Medifocus, Inc Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Medifocus, Inc Recent Developments and Future Plans

2.13 Medtronic plc

2.13.1 Medtronic plc Details

2.13.2 Medtronic plc Major Business

2.13.3 Medtronic plc Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.13.4 Medtronic plc Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Medtronic plc Recent Developments and Future Plans

2.14 Merit Medical Systems, Inc.

2.14.1 Merit Medical Systems, Inc. Details

2.14.2 Merit Medical Systems, Inc. Major Business

2.14.3 Merit Medical Systems, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.14.4 Merit Medical Systems, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Merit Medical Systems, Inc. Recent Developments and Future Plans

2.15 NeoTract, Inc.

2.15.1 NeoTract, Inc. Details

2.15.2 NeoTract, Inc. Major Business

2.15.3 NeoTract, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.15.4 NeoTract, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 NeoTract, Inc. Recent Developments and Future Plans

2.16 Olympus Corporation

2.16.1 Olympus Corporation Details

2.16.2 Olympus Corporation Major Business

2.16.3 Olympus Corporation Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.16.4 Olympus Corporation Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Olympus Corporation Recent Developments and Future Plans

2.17 Pnn Medical AS

2.17.1 Pnn Medical AS Details

2.17.2 Pnn Medical AS Major Business

2.17.3 Pnn Medical AS Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.17.4 Pnn Medical AS Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Pnn Medical AS Recent Developments and Future Plans

2.18 PROCEPT BioRobotics

2.18.1 PROCEPT BioRobotics Details

2.18.2 PROCEPT BioRobotics Major Business

2.18.3 PROCEPT BioRobotics Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.18.4 PROCEPT BioRobotics Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 PROCEPT BioRobotics Recent Developments and Future Plans

2.19 Richard Wolf GmbH

2.19.1 Richard Wolf GmbH Details

2.19.2 Richard Wolf GmbH Major Business

2.19.3 Richard Wolf GmbH Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.19.4 Richard Wolf GmbH Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 Richard Wolf GmbH Recent Developments and Future Plans

2.20 Sophiris Bio, Inc.

2.20.1 Sophiris Bio, Inc. Details

2.20.2 Sophiris Bio, Inc. Major Business

2.20.3 Sophiris Bio, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.20.4 Sophiris Bio, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 Sophiris Bio, Inc. Recent Developments and Future Plans

2.21 Stryker Corporation

2.21.1 Stryker Corporation Details

2.21.2 Stryker Corporation Major Business

2.21.3 Stryker Corporation Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

2.21.4 Stryker Corporation Benign Prostatic Hyperplasia Treatment Equipments Revenue, Gross Margin and Market Share (2019-2021)

2.21.5 Stryker Corporation Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Benign Prostatic Hyperplasia Treatment Equipments Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Benign Prostatic Hyperplasia Treatment Equipments Players Market Share

3.2.2 Top 10 Benign Prostatic Hyperplasia Treatment Equipments Players Market Share

3.2.3 Market Competition Trend

3.3 Benign Prostatic Hyperplasia Treatment Equipments Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Benign Prostatic Hyperplasia Treatment Equipments Revenue and Market Share by Type (2016-2021)

4.2 Global Benign Prostatic Hyperplasia Treatment Equipments Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Application (2016-2021)

5.2 Benign Prostatic Hyperplasia Treatment Equipments Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Type (2016-2026)

6.2 North America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Application (2016-2026)

6.3 North America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country

6.3.1 North America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Country (2016-2026)

6.3.2 United States Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast (2016-2026)

6.3.3 Canada Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast (2016-2026)

6.3.4 Mexico Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue by Type (2016-2026)

7.2 Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue by Application (2016-2026)

7.3 Europe Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country

7.3.1 Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue by Country (2016-2026)

7.3.2 Germany Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast (2016-2026)

7.3.3 France Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast (2016-2026)

7.3.5 Russia Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast (2016-2026)

7.3.6 Italy Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue by Type (2016-2026)

8.2 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue by Application (2016-2026)

8.3 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Market Size by Region

8.3.1 Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue by Region (2016-2026)

8.3.2 China Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast (2016-2026)

8.3.3 Japan Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast (2016-2026)

8.3.4 South Korea Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast (2016-2026)

8.3.5 India Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast (2016-2026)

8.3.7 Australia Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Type (2016-2026)

9.2 South America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Application (2016-2026)

9.3 South America Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country

9.3.1 South America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Country (2016-2026)

9.3.2 Brazil Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast (2016-2026)

9.3.3 Argentina Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue by Type (2016-2026)

10.2 Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue by Application (2016-2026)

10.3 Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Market Size by Country

10.3.1 Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue by Country (2016-2026)

10.3.2 Turkey Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast (2016-2026)

10.3.4 UAE Benign Prostatic Hyperplasia Treatment Equipments Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Benign Prostatic Hyperplasia Treatment Equipments Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million) by Region (2016-2021)

Table 5. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Region (2021-2026)

Table 6. Advin Urology Corporate Information, Head Office, and Major Competitors

Table 7. Advin Urology Major Business

Table 8. Advin Urology Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 9. Advin Urology Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Biolitec Corporate Information, Head Office, and Major Competitors

Table 11. Biolitec Major Business

Table 12. Biolitec Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 13. Biolitec Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Boston Scientific Corporation Corporate Information, Head Office, and Major Competitors

Table 15. Boston Scientific Corporation Major Business

Table 16. Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 17. Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. CONMED Corporate Information, Head Office, and Major Competitors

Table 19. CONMED Major Business

Table 20. CONMED Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 21. CONMED Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Convergent Laser Technologies Corporate Information, Head Office, and Major Competitors

Table 23. Convergent Laser Technologies Major Business

Table 24. Convergent Laser Technologies Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 25. Convergent Laser Technologies Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. CoreTherm Medical, Inc. Corporate Information, Head Office, and Major Competitors

Table 27. CoreTherm Medical, Inc. Major Business

Table 28. CoreTherm Medical, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 29. CoreTherm Medical, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. HistoSonics, Inc. Corporate Information, Head Office, and Major Competitors

Table 31. HistoSonics, Inc. Major Business

Table 32. HistoSonics, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 33. HistoSonics, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. JenaSurgical GmbH Corporate Information, Head Office, and Major Competitors

Table 35. JenaSurgical GmbH Major Business

Table 36. JenaSurgical GmbH Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 37. JenaSurgical GmbH Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. KARL STORZ Corporate Information, Head Office, and Major Competitors

Table 39. KARL STORZ Major Business

Table 40. KARL STORZ Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 41. KARL STORZ Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. LISA Laser Products GmbH Corporate Information, Head Office, and Major Competitors

Table 43. LISA Laser Products GmbH Major Business

Table 44. LISA Laser Products GmbH Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 45. LISA Laser Products GmbH Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Lumenis Ltd. Corporate Information, Head Office, and Major Competitors

Table 47. Lumenis Ltd. Major Business

Table 48. Lumenis Ltd. Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 49. Lumenis Ltd. Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Medifocus, Inc Corporate Information, Head Office, and Major Competitors

Table 51. Medifocus, Inc Major Business

Table 52. Medifocus, Inc Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 53. Medifocus, Inc Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Medtronic plc Corporate Information, Head Office, and Major Competitors

Table 55. Medtronic plc Major Business

Table 56. Medtronic plc Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 57. Medtronic plc Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Merit Medical Systems, Inc. Corporate Information, Head Office, and Major Competitors

Table 59. Merit Medical Systems, Inc. Major Business

Table 60. Merit Medical Systems, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 61. Merit Medical Systems, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. NeoTract, Inc. Corporate Information, Head Office, and Major Competitors

Table 63. NeoTract, Inc. Major Business

Table 64. NeoTract, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 65. NeoTract, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Olympus Corporation Corporate Information, Head Office, and Major Competitors

Table 67. Olympus Corporation Major Business

Table 68. Olympus Corporation Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 69. Olympus Corporation Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Pnn Medical AS Corporate Information, Head Office, and Major Competitors

Table 71. Pnn Medical AS Major Business

Table 72. Pnn Medical AS Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 73. Pnn Medical AS Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. PROCEPT BioRobotics Corporate Information, Head Office, and Major Competitors

Table 75. PROCEPT BioRobotics Major Business

Table 76. PROCEPT BioRobotics Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 77. PROCEPT BioRobotics Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Richard Wolf GmbH Corporate Information, Head Office, and Major Competitors

Table 79. Richard Wolf GmbH Major Business

Table 80. Richard Wolf GmbH Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 81. Richard Wolf GmbH Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. Sophiris Bio, Inc. Corporate Information, Head Office, and Major Competitors

Table 83. Sophiris Bio, Inc. Major Business

Table 84. Sophiris Bio, Inc. Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 85. Sophiris Bio, Inc. Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. Stryker Corporation Corporate Information, Head Office, and Major Competitors

Table 87. Stryker Corporation Major Business

Table 88. Stryker Corporation Benign Prostatic Hyperplasia Treatment Equipments Product and Solutions

Table 89. Stryker Corporation Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 90. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million) by Players (2019-2021)

Table 91. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Share by Players (2019-2021)

Table 92. Breakdown of Benign Prostatic Hyperplasia Treatment Equipments by Company Type (Tier 1, Tier 2 and Tier 3)

Table 93. Benign Prostatic Hyperplasia Treatment Equipments Players Head Office, Products and Services Provided

Table 94. Benign Prostatic Hyperplasia Treatment Equipments Mergers & Acquisitions in the Past Five Years

Table 95. Benign Prostatic Hyperplasia Treatment Equipments New Entrants and Expansion Plans

Table 96. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million) by Type (2016-2021)

Table 97. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Share by Type (2016-2021)

Table 98. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Forecast by Type (2021-2026)

Table 99. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue by Application (2016-2021)

Table 100. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Forecast by Application (2021-2026)

Table 101. North America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Type (2016-2021) & (USD Million)

Table 102. North America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Type (2021-2026) & (USD Million)

Table 103. North America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Application (2016-2021) & (USD Million)

Table 104. North America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Application (2021-2026) & (USD Million)

Table 105. North America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Country (2016-2021) & (USD Million)

Table 106. North America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Country (2021-2026) & (USD Million)

Table 107. Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue by Type (2016-2021) & (USD Million)

Table 108. Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue by Type (2021-2026) & (USD Million)

Table 109. Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue by Application (2016-2021) & (USD Million)

Table 110. Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue by Application (2021-2026) & (USD Million)

Table 111. Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue by Country (2016-2021) & (USD Million)

Table 112. Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue by Country (2021-2026) & (USD Million)

Table 113. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue by Type (2016-2021) & (USD Million)

Table 114. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue by Type (2021-2026) & (USD Million)

Table 115. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue by Application (2016-2021) & (USD Million)

Table 116. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue by Application (2021-2026) & (USD Million)

Table 117. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue by Region (2016-2021) & (USD Million)

Table 118. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue by Region (2021-2026) & (USD Million)

Table 119. South America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Type (2016-2021) & (USD Million)

Table 120. South America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Type (2021-2026) & (USD Million)

Table 121. South America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Application (2016-2021) & (USD Million)

Table 122. South America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Application (2021-2026) & (USD Million)

Table 123. South America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Country (2016-2021) & (USD Million)

Table 124. South America Benign Prostatic Hyperplasia Treatment Equipments Revenue by Country (2021-2026) & (USD Million)

Table 125. Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue by Type (2016-2021) & (USD Million)

Table 126. Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue by Type (2021-2026) & (USD Million)

Table 127. Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue by Application (2016-2021) & (USD Million)

Table 128. Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue by Application (2021-2026) & (USD Million)

Table 129. Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue by Country (2016-2021) & (USD Million)

Table 130. Middle East & Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Benign Prostatic Hyperplasia Treatment Equipments Picture

Figure 2. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Type in 2020

Figure 3. Surgical Treatment Equipments

Figure 4. Minimally Invasive Treatment Equipments

Figure 5. Laser Treatment Equipments

Figure 6. Other

Figure 7. Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Application in 2020

Figure 8. Hospitals and Clinics Picture

Figure 9. Ambulatory Surgical Centers(ASC) Picture

Figure 10. Home Picture

Figure 11. Others Picture

Figure 12. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Region (2016-2026)

Figure 15. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Region in 2020

Figure 16. North America Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Benign Prostatic Hyperplasia Treatment Equipments Market Drivers

Figure 22. Benign Prostatic Hyperplasia Treatment Equipments Market Restraints

Figure 23. Benign Prostatic Hyperplasia Treatment Equipments Market Trends

Figure 24. Advin Urology Recent Developments and Future Plans

Figure 25. Biolitec Recent Developments and Future Plans

Figure 26. Boston Scientific Corporation Recent Developments and Future Plans

Figure 27. CONMED Recent Developments and Future Plans

Figure 28. Convergent Laser Technologies Recent Developments and Future Plans

Figure 29. CoreTherm Medical, Inc. Recent Developments and Future Plans

Figure 30. HistoSonics, Inc. Recent Developments and Future Plans

Figure 31. JenaSurgical GmbH Recent Developments and Future Plans

Figure 32. KARL STORZ Recent Developments and Future Plans

Figure 33. LISA Laser Products GmbH Recent Developments and Future Plans

Figure 34. Lumenis Ltd. Recent Developments and Future Plans

Figure 35. Medifocus, Inc Recent Developments and Future Plans

Figure 36. Medtronic plc Recent Developments and Future Plans

Figure 37. Merit Medical Systems, Inc. Recent Developments and Future Plans

Figure 38. NeoTract, Inc. Recent Developments and Future Plans

Figure 39. Olympus Corporation Recent Developments and Future Plans

Figure 40. Pnn Medical AS Recent Developments and Future Plans

Figure 41. PROCEPT BioRobotics Recent Developments and Future Plans

Figure 42. Richard Wolf GmbH Recent Developments and Future Plans

Figure 43. Sophiris Bio, Inc. Recent Developments and Future Plans

Figure 44. Stryker Corporation Recent Developments and Future Plans

Figure 45. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Share by Players in 2020

Figure 46. Benign Prostatic Hyperplasia Treatment Equipments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 47. Global Top 3 Players Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share in 2020

Figure 48. Global Top 10 Players Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share in 2020

Figure 49. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 50. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Share by Type in 2020

Figure 51. Global Benign Prostatic Hyperplasia Treatment Equipments Market Share Forecast by Type (2021-2026)

Figure 52. Global Benign Prostatic Hyperplasia Treatment Equipments Revenue Share by Application in 2020

Figure 53. Global Benign Prostatic Hyperplasia Treatment Equipments Market Share Forecast by Application (2021-2026)

Figure 54. North America Benign Prostatic Hyperplasia Treatment Equipments Sales Market Share by Type (2016-2026)

Figure 55. North America Benign Prostatic Hyperplasia Treatment Equipments Sales Market Share by Application (2016-2026)

Figure 56. North America Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Country (2016-2026)

Figure 57. United States Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Canada Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Mexico Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Europe Benign Prostatic Hyperplasia Treatment Equipments Sales Market Share by Type (2016-2026)

Figure 61. Europe Benign Prostatic Hyperplasia Treatment Equipments Sales Market Share by Application (2016-2026)

Figure 62. Europe Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Country (2016-2026)

Figure 63. Germany Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. France Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. United Kingdom Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Russia Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Italy Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Sales Market Share by Type (2016-2026)

Figure 69. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Sales Market Share by Application (2016-2026)

Figure 70. Asia-Pacific Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Region (2016-2026)

Figure 71. China Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Japan Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. South Korea Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. India Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Southeast Asia Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Australia Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. South America Benign Prostatic Hyperplasia Treatment Equipments Sales Market Share by Type (2016-2026)

Figure 78. South America Benign Prostatic Hyperplasia Treatment Equipments Sales Market Share by Application (2016-2026)

Figure 79. South America Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Country (2016-2026)

Figure 80. Brazil Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Argentina Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Middle East and Africa Benign Prostatic Hyperplasia Treatment Equipments Sales Market Share by Type (2016-2026)

Figure 83. Middle East and Africa Benign Prostatic Hyperplasia Treatment Equipments Sales Market Share by Application (2016-2026)

Figure 84. Middle East and Africa Benign Prostatic Hyperplasia Treatment Equipments Revenue Market Share by Country (2016-2026)

Figure 85. Turkey Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 86. Saudi Arabia Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 87. UAE Benign Prostatic Hyperplasia Treatment Equipments Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 88. Methodology

Figure 89. Research Process and Data Source